Filing Details
- Accession Number:
- 0001209191-21-014543
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-25 20:52:21
- Reporting Period:
- 2021-02-23
- Accepted Time:
- 2021-02-25 20:52:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649989 | Outlook Therapeutics Inc. | OTLK | Biological Products, (No Disgnostic Substances) (2836) | 383982704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760511 | Jeff Evanson | C/O Outlook Therapeutics, Inc. 4260 Us Route 1 Monmouth Junction NJ 08852 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-23 | 8,554 | $2.09 | 1,141,930 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.
Billionaire Hedge Funds
